3/28
08:20 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $66.00 to $52.00. They now have a "buy" rating on the stock.
Medium
Report
AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $66.00 to $52.00. They now have a "buy" rating on the stock.
3/28
08:03 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at BTIG Research.
Medium
Report
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at BTIG Research.
3/27
10:26 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at JPMorgan Chase & Co. from $51.00 to $46.00. They now have an "overweight" rating on the stock.
Low
Report
AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at JPMorgan Chase & Co. from $51.00 to $46.00. They now have an "overweight" rating on the stock.
3/27
08:15 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $51.00 price target on the stock.
Medium
Report
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $51.00 price target on the stock.
3/21
08:09 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $51.00 price target on the stock.
Low
Report
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $51.00 price target on the stock.
3/12
08:00 am
atrc
AtriCure to Host Analyst & Investor Day on March 26, 2025
Medium
Report
AtriCure to Host Analyst & Investor Day on March 26, 2025
2/13
11:55 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Oppenheimer Holdings Inc. from $36.00 to $45.00. They now have an "outperform" rating on the stock.
Low
Report
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Oppenheimer Holdings Inc. from $36.00 to $45.00. They now have an "outperform" rating on the stock.
2/13
11:21 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Piper Sandler from $40.00 to $50.00. They now have an "overweight" rating on the stock.
Low
Report
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Piper Sandler from $40.00 to $50.00. They now have an "overweight" rating on the stock.
2/13
10:00 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Stifel Nicolaus from $36.00 to $48.00. They now have a "buy" rating on the stock.
Low
Report
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Stifel Nicolaus from $36.00 to $48.00. They now have a "buy" rating on the stock.
2/13
08:10 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $51.00 price target on the stock.
High
Report
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $51.00 price target on the stock.
2/13
08:10 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Canaccord Genuity Group Inc. from $61.00 to $66.00. They now have a "buy" rating on the stock.
High
Report
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Canaccord Genuity Group Inc. from $61.00 to $66.00. They now have a "buy" rating on the stock.
2/13
04:09 am
atrc
AtriCure Inc (ATRC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]
Medium
Report
AtriCure Inc (ATRC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]
2/12
04:28 pm
atrc
AtriCure Reports Fourth Quarter 2024 and Full Year 2024 Financial Results [Yahoo! Finance]
Low
Report
AtriCure Reports Fourth Quarter 2024 and Full Year 2024 Financial Results [Yahoo! Finance]
2/12
04:01 pm
atrc
AtriCure Reports Fourth Quarter 2024 and Full Year 2024 Financial Results
Medium
Report
AtriCure Reports Fourth Quarter 2024 and Full Year 2024 Financial Results
2/11
10:59 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at JPMorgan Chase & Co. from $40.00 to $51.00. They now have an "overweight" rating on the stock.
Low
Report
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at JPMorgan Chase & Co. from $40.00 to $51.00. They now have an "overweight" rating on the stock.
2/10
10:20 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $60.00 price target on the stock.
Low
Report
AtriCure, Inc. (NASDAQ: ATRC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $60.00 price target on the stock.
2/3
08:56 am
atrc
Quantum Workplace Acquires WorkDove to Expand Its Footprint in Performance Management Space
Medium
Report
Quantum Workplace Acquires WorkDove to Expand Its Footprint in Performance Management Space
1/22
09:05 am
atrc
AtriCure to Announce Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]
Low
Report
AtriCure to Announce Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]
1/22
08:14 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Needham & Company LLC from $40.00 to $51.00. They now have a "buy" rating on the stock.
Low
Report
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Needham & Company LLC from $40.00 to $51.00. They now have a "buy" rating on the stock.
1/22
08:00 am
atrc
AtriCure to Announce Fourth Quarter and Full Year 2024 Financial Results
Low
Report
AtriCure to Announce Fourth Quarter and Full Year 2024 Financial Results
1/13
01:46 pm
atrc
AtriCure reports preliminary results for fourth quarter [Seeking Alpha]
Low
Report
AtriCure reports preliminary results for fourth quarter [Seeking Alpha]
1/13
10:58 am
atrc
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $40.00 price target on the stock.
Medium
Report
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $40.00 price target on the stock.
1/13
08:00 am
atrc
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 2025, and Announces Upcoming Analyst & Investor Day
Medium
Report
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 2025, and Announces Upcoming Analyst & Investor Day